Houlihan Lokey
HLINYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $148.03 Prior regular-session close from the quote source.
- $145.24–$148.54 Regular-session low and high so far today.
- 408.0K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Jan 28 projected Projected for 2027-01-28 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $112.83–$195.06 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own HLI if Houlihan Lokey creates durable value by combining a market-leading, senior-banker-driven advisory franchise in mid-market M&A with a countercyclical restructuring business and a low-capital, high-conversion fee model that generates recurring high margins and cash flow.
HLI price history
Loading recent earnings…
Investment thesis
What must happen next
HLI's reputation and senior‑banker footprint in the mid‑market will keep completion-fee-rich M&A volumes resilient, sustaining revenue growth even if bulge‑bracket activity softens.StrengtheningMateriality: High
Revenue increased from $1,914,404,000 (FY2024) to $2,389,416,000 (FY2025) to $2,617,516,000 (FY2026), showing durability and growth. If true, revenue and fees remain steady and earnings growth is durable; if false, revenue will be far more cyclical and margins will compress as completion fees fall.
Watch: Bulge‑bracket banks or large boutiques materially target the sub‑$1B sell‑side with aggressive pricing or exclusive sponsor relationships, eroding HLI's win rate.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Revenue increased from $1,914,404,000 (FY2024) to $2,389,416,000 (FY2025) to $2,617,516,000 (FY2026), showing durability and growth.
Open source ↗HLI's Financial Restructuring practice provides countercyclical, high‑value engagements that stabilize cash flow and revenue when M&A activity slows, because restructuring fees are driven by elevated leverage and interest‑rate pressures.StrengtheningMateriality: High
Operating cash flow rose from $328,458,000 (FY2024) to $848,609,000 (FY2025) and was $704,131,000 (FY2026), indicating strong cash conversion during periods of active advisory flows. If FR remains active, overall cash conversion and revenue volatility are reduced; if restructuring activity fades, downside in weak M&A periods will be larger.
Watch: A material and sustained decline in interest rates and corporate leverage that reduces restructuring mandate volume.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating cash flow rose from $328,458,000 (FY2024) to $848,609,000 (FY2025) and was $704,131,000 (FY2026), indicating strong cash conversion during periods.
Open source ↗The senior‑partner, low‑capital advisory model will continue to convert fee revenue into high operating income and EPS growth, because advisory work requires limited fixed capital and benefits from strong operating leverage.StrengtheningMateriality: Medium
Operating income increased from $373,234,000 (FY2024) to $502,567,000 (FY2025) to $527,019,000 (FY2026), showing ability to scale profits with revenue. If true, HLI will sustain strong operating margins and free cash to support M&A and shareholder returns; if false, rising fixed or compensation costs will compress margins and ROE.
Watch: Compensation expense rising faster than revenue (e.g., aggressive hiring or bonuses to retain/poach MDs) reducing operating leverage.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating income increased from $373,234,000 (FY2024) to $502,567,000 (FY2025) to $527,019,000 (FY2026), showing ability to scale profits with revenue.
Open source ↗Expanding internationally and selectively acquiring capabilities can drive incremental revenue and client access, provided integration preserves senior‑level client coverage and fee economics.HoldingMateriality: Medium
Total assets increased from $3,170,759,000 (FY2025) to $4,309,000,000 (FY2026), consistent with balance‑sheet growth supporting expansion. If HLI integrates well, growth accelerates and diversifies revenue; poor execution leads to goodwill write‑downs, lower margins, and distracted senior bankers.
Watch: Acquisitions that are not integrated, leading to client churn or dilution of fee margins.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Total assets increased from $3,170,759,000 (FY2025) to $4,309,000,000 (FY2026), consistent with balance‑sheet growth supporting expansion.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
HLI's reputation and senior‑banker footprint in the mid‑market will keep completion-fee-rich M&A volumes resilient, sustaining revenue growth even if bulge‑bracket activity softens. If true, revenue and fees remain steady and earnings growth is durable; if false, revenue will be far more cyclical and margins will compress as completion fees fall.
HLI's Financial Restructuring practice provides countercyclical, high‑value engagements that stabilize cash flow and revenue when M&A activity slows, because restructuring fees are driven by elevated leverage and interest‑rate pressures. If FR remains active, overall cash conversion and revenue volatility are reduced; if restructuring activity fades, downside in weak M&A periods will be larger.
The senior‑partner, low‑capital advisory model will continue to convert fee revenue into high operating income and EPS growth, because advisory work requires limited fixed capital and benefits from strong operating leverage. If true, HLI will sustain strong operating margins and free cash to support M&A and shareholder returns; if false, rising fixed or compensation costs will compress margins and ROE.
Expanding internationally and selectively acquiring capabilities can drive incremental revenue and client access, provided integration preserves senior‑level client coverage and fee economics. If HLI integrates well, growth accelerates and diversifies revenue; poor execution leads to goodwill write‑downs, lower margins, and distracted senior bankers.
All standing thesis claims
Original report summary
Houlihan Lokey creates durable value by combining a market-leading, senior-banker-driven advisory franchise in mid-market M&A with a countercyclical restructuring business and a low-capital, high-conversion fee model that generates recurring high margins and cash flow.
Bull case and bear case
Bull case and bear case for Houlihan Lokey
Where the evidence on Houlihan Lokey stands: Holding on the latest evidence (Nov 3, 2026). Of its 4 thesis points, 3 strengthening and 1 holding.
Bull case: what the evidence supports
HLI's reputation and senior‑banker footprint in the mid‑market will keep completion-fee-rich M&A volumes resilient, sustaining revenue growth even if bulge‑bracket activity softens.
HLI's Financial Restructuring practice provides countercyclical, high‑value engagements that stabilize cash flow and revenue when M&A activity slows, because restructuring fees are driven by elevated leverage and interest‑rate pressures.
The senior‑partner, low‑capital advisory model will continue to convert fee revenue into high operating income and EPS growth, because advisory work requires limited fixed capital and benefits from strong operating leverage.
Expanding internationally and selectively acquiring capabilities can drive incremental revenue and client access, provided integration preserves senior‑level client coverage and fee economics.
Bear case: what would count against it
Bulge‑bracket banks or large boutiques materially target the sub‑$1B sell‑side with aggressive pricing or exclusive sponsor relationships, eroding HLI's win rate.
A material and sustained decline in interest rates and corporate leverage that reduces restructuring mandate volume.
Compensation expense rising faster than revenue (e.g., aggressive hiring or bonuses to retain/poach MDs) reducing operating leverage.
Thesis-Break Engine
What has broken in Houlihan Lokey’s thesis
Each break OptimistFi flagged on Houlihan Lokey, dated — with what has historically followed the same kind of break across the market, not a forecast for Houlihan Lokey.
- Price target fell below the stockcondition set before this filing
Across all companies, this kind of break has happened 1,809 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.
- CEO / officer changecondition set before this filing
Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.
Early warning
The break condition read on the trailing twelve months through Houlihan Lokey’s latest quarterly report, ahead of the annual figure it is written on.
- Revenue decline, trailing 12 months
Across all companies, this kind of early warning has happened 3,039 times before. Those stocks beat comparable companies by a median of 1% over the next six months, and 32% of them trailed it by 10 points or more.
Several kinds of break have stacked on Houlihan Lokey at once. A cluster is a stronger read than any one signal alone.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Houlihan Lokey filed an SEC 8-K on 2026-10-28: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Houlihan Lokey filed an SEC 8-K on 2026-10-05: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Houlihan Lokey filed an SEC 8-K on 2026-09-22: Director or principal officer change. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Bulge‑bracket banks or large boutiques materially target the sub‑$1B sell‑side with aggressive pricing or exclusive sponsor relationships, eroding HLI's win rate.
- A material and sustained decline in interest rates and corporate leverage that reduces restructuring mandate volume.
- Compensation expense rising faster than revenue (e.g., aggressive hiring or bonuses to retain/poach MDs) reducing operating leverage.
- Acquisitions that are not integrated, leading to client churn or dilution of fee margins.
HLI news
Loading headlines…
Financial statements
HLI income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
HLI: quick answers
- When does Houlihan Lokey (HLI) report earnings next?
- Houlihan Lokey's next results are projected for January 28, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 28, 2026. Earnings calendar
- What is HLI's short interest?
- As of October 30, 2026, 2.1M HLI shares were sold short, 3.95% of its shares outstanding, down 0.9% from the count before. At the stock's average daily volume that is 2.9 days to cover. FINRA publishes the count twice a month. HLI short interest history
- Which well-known investors own HLI?
- 1 of the 37 well-known funds tracked here reported HLI shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios
HLI in well-known investors’ portfolios
1 of 37 funds reported HLI shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Ray DalioBridgewater Associates | 0.01% | $2.1M | −22.1% | Q2 2026 |
